Emerging concepts in cardiac matrix biology

被引:53
作者
Espira, Leon [1 ]
Czubryt, Michael P. [1 ]
机构
[1] St Boniface Gen Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada
关键词
extracellular matrix; cardiac fibrosis; signaling; antifibrotics; development; collagen; proteoglycan; growth factors; HYPERTENSIVE HEART-DISEASE; COLLAGEN CROSS-LINKING; HUMAN MYOCARDIAL SCARS; EXTRACELLULAR-MATRIX; GROWTH-FACTOR; MOUSE MACROPHAGES; GENE-EXPRESSION; METALLOPROTEINASE INHIBITION; HYALURONAN FRAGMENTS; DILATED CARDIOMYOPATHY;
D O I
10.1139/Y09-105
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cardiac extracellular matrix, far from being merely a static support structure for the heart, is now recognized to play central roles in cardiac development, morphology, and cell signaling. Recent studies have better shaped our understanding of the tremendous complexity of this active and dynamic network. By activating intracellular signal cascades, the matrix transduces myocardial physical forces into responses by myocytes and fibroblasts, affecting their function and behavior. In turn, cardiac fibroblasts and myocytes play active roles in remodeling the matrix. Coupled with the ability of the matrix to act as a dynamic reservoir for growth factors and cytokines, this interplay between the support structure and embedded cells has the potential to exert dramatic effects on cardiac structure and function. One of the clearest examples of this occurs when cell-matrix interactions are altered inappropriately, contributing to pathological fibrosis and heart failure. This review will examine some of the recent concepts that have emerged regarding exactly how the cardiac matrix mediates these effects, how our collective vision of the matrix has changed as a result, and the current state of attempts to pharmacologically treat fibrosis.
引用
收藏
页码:996 / 1008
页数:13
相关论文
共 111 条
[1]   A site on laminin α5, AQARSAASKVKVSMKF, induces inflammatory cell production of matrix metalloproteinase-9 and chemotaxis [J].
Adair-Kirk, TL ;
Atkinson, JJ ;
Broekelmann, TJ ;
Doi, M ;
Tryggvason, K ;
Miner, JH ;
Mecham, RP ;
Senior, RM .
JOURNAL OF IMMUNOLOGY, 2003, 171 (01) :398-406
[2]   Reversal of cardiac dysfunction by selective ET-A receptor antagonism [J].
Allan, A ;
Fenning, A ;
Levick, S ;
Hoey, A ;
Brown, L .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (06) :846-853
[3]   Novel pirfenidone analogues: Synthesis of pyridin-2-ones for the treatment of pulmonary fibrosis [J].
Ammar, Yousry A. ;
Ismail, Magda M. F. ;
El-Sehrawi, Hend M. ;
Noaman, Eman ;
Bayomi, Ashraf H. ;
Shawer, Taghreed Z. .
ARCHIV DER PHARMAZIE, 2006, 339 (08) :429-436
[4]  
Ammarguellat F, 2001, CIRCULATION, V103, P319
[5]   Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats [J].
Badenhorst, D ;
Maseko, M ;
Tsotetsi, OJ ;
Naidoo, A ;
Brooksbank, R ;
Norton, GR ;
Woodiwiss, AJ .
CARDIOVASCULAR RESEARCH, 2003, 57 (03) :632-641
[6]   Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction [J].
Bauersachs, J ;
Galuppo, P ;
Fraccarollo, D ;
Christ, M ;
Ertl, G .
CIRCULATION, 2001, 104 (09) :982-985
[7]  
Bendall JK, 2002, ARCH MAL COEUR VAISS, V95, P1226
[8]   Functional structure and composition of the extracellular matrix [J].
Bosman, FT ;
Stamenkovic, I .
JOURNAL OF PATHOLOGY, 2003, 200 (04) :423-428
[9]   Extracellular matrix and integrin signalling: the shape of things to come [J].
Boudreau, J ;
Jones, PL .
BIOCHEMICAL JOURNAL, 1999, 339 :481-488
[10]   A somitic compartment of tendon progenitors [J].
Brent, AE ;
Schweitzer, R ;
Tabin, CJ .
CELL, 2003, 113 (02) :235-248